Articles
| Open Access |
DOI: Integral Assessment Of Risk Factors Affecting The Development Of Chronic Kidney Disease And Optimization Of The Way Of Prevention
Akhmedova Nilufar Sharipovna , Bukhara State Medical Institute, Bukhara, UzbekistanAbstract
Everywhere today, chronic kidney disease (CKD) is a general medical problem with profound socio-medical and economic consequences associated with its widespread prevalence among the population, disability, mortality due to the development of the terminal stage of the disease. The purpose of this stage of the work was to identify and assess the risk factors associated with albuminuria affecting the development of CKD. Based on these data, a mathematical model has been developed that allows calculating the risk index (RI) of CKD development.
Keywords
Chronic kidney disease, forecast
References
Akhmedova N.Sh. Features of screening of renal function in an outpatient setting // MEDICUS (International medical journal). –Volgograd, 2019, No. 2 (26). - C 17-21 (IF - 0.23).
Gulov M.K., Abdullaev S.M., Rafiev Kh.K. Quality of life in patients with chronic kidney disease // Russian medical and biological bulletin named after Academician I.L. Pavlov. 2018, No. 4. - P. 493–499.
Maksimov Zh.I., Maksimov D.M. Screening: a modern perspective on early diagnosis and prevention of chronic non-communicable diseases // Archive of Internal Medicine, Ural, 2014 - pp. 52–56.
Statsenko M.E., Turkina I.A. Visceral obesity as a marker of the risk of multi-organ damage // Bulletin of Volgograd State Medical University. - 2017, No. 1. - P.10-14.
Shvetsov M.Yu. Chronic kidney disease as a general medical problem: modern principles of nephroprophylaxis and nephroprotective therapy // Zh. Comsiliummedicum. - 2014, T. 16, No. 7. - P. 51–64.
Akhmedova N.Sh.The importance of proteinuria as a predictor of diagnosis and a factor for the development of chronic kidney ddisease// European science review. –Vienna, – 2018.–№ 7-8 P. 84-85(14.00.00. №19).
James M.T., Hemmelgarn B.R., Tonelli M.: Early recognition and prevention of chronic kidney disease // Lancet 375:2010 – Р. 1296–1309.
Article Statistics
Copyright License
Copyright (c) 2020 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.